A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?-Reference-Cited by-同舟云学术

A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?

Published:2022-03-15 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Trombetta Claudia Maria¹^ORCID,Marchi Serena¹^ORCID,Viviani Simonetta¹^ORCID,Manenti Alessandro²³^ORCID,Casa Elisa³,Dapporto Francesca³,Remarque Edmond J.⁴^ORCID,Bollati Valentina⁵^ORCID,Manini Ilaria¹^ORCID,Lazzeri Giacomo¹^ORCID,Montomoli Emanuele¹²³^ORCID

Affiliation:

1. Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy

2. VisMederi srl, Siena, Italy

3. VisMederi Research srl, Siena, Italy

4. Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

5. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2047582

Reference63 articles.

1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. [accessed 2021 Nov 29]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.

2. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. [accessed 2021 Nov 29]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-covid-2019-and-the-virus-that-causes-it

3. SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence

4. eCDC. Immune responses and immunity to SARS-CoV-2. 2021 29/11/2021]. [accessed 2021 Nov 29]. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/immune-responses.

5. SARS‐CoV‐2 antibodies: IgA correlates with severity of disease in early COVID‐19 infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do variations in anomalous mortality in Europe in fall and winter of 2019–2020 tell us anything on the timing of SARS‐CoV‐2 outbreak?;Population, Space and Place;2023-10-31

2. Asymptomatic and Mild SARS-CoV-2 Infections in a Hungarian Outpatient Cohort in the First Year of the COVID-19 Pandemic;Tropical Medicine and Infectious Disease;2023-03-29

3. Infodemiology of RSV in Italy (2017–2022): An Alternative Option for the Surveillance of Incident Cases in Pediatric Age?;Children;2022-12-16

4. Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021);International Journal of Infectious Diseases;2022-11

5. SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy;Viruses;2022-06-30